Page 159 - metagenics-catalogue_c_en_5
P. 159

Meta Lipoate 300





                Product description

                Alpha-lipoic acid is an indispensable cofactor in the energy production in
                the mitochondrions (power plants); a surplus of which is used as antioxidant.
                It is many-sided: it is active both in an aqueous (intra- and extracellular)
                and in a lipid environment (in cell en mitochondrion membranes), is able to
                cope with a broad range of free radicals and works synergetically with
                vitamins such as vitamin C and E.
                Useful in support of the heart, blood circulation, brains and liver, useful
                in cases of being tired and aging


                Ingredients

                 INGREDIENTS PER TABLET
                 Alpha lipoic acid                                                          300 mg
                 Auxiliary substances : microcrystalline cellulose, hydrogenated cottonseed
                 oil, sodium carboxymethylcellulose, magnesium stearate, silicium dioxide



                Packaging

                60 tablets

                Recommended use

                1 to 2 tablets daily or as recommended
                Precaution


                Do not use in the following cases: no known cases


























         Metagenics Europe | info@metagenics.eu | +32(0)59/80.58.24 | www.metagenics.eu      Drawn Up 15/12/2012    Meta Lipoate 300    4341
       The information given in this publication is intended explicitly for readers who deal with health and nutrition on professional grounds. In the interest of public health this publication is not intended
       for lay people or consumers. Publisher and authors declare that this publication has been compiled meticulously and to the best of their knowledge. However, they cannot be held responsible for
       the comprehensiveness or potential mistakes of this publication. Publisher and authors do not accept any responsibility for damage, of any kind, resulting from actions and/or decisions based on the
       contents of this publication.
   154   155   156   157   158   159   160   161   162   163   164